Pregled bibliografske jedinice broj: 1192445
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy // European journal of endocrinology, 185 (2021), 4; G43-G67 doi:10.1530/eje-21-0479 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1192445 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The 2021 European Group on Graves’
orbitopathy (EUGOGO) clinical practice
guidelines for the medical management of
Graves’ orbitopathy
Autori
Bartalena, L. ; Kahaly, G. J. ; Baldeschi, L. ; Dayan, C. M. ; Eckstein, A. ; Marcocci, C. ; Marino, M. ; Vaidya, B. ; Wiersinga, W. M.
Kolaboracija
EUGOGO
Izvornik
European journal of endocrinology (0804-4643) 185
(2021), 4;
G43-G67
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Graves' orbitopathy ; guidelines
Sažetak
Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease (GD). Choice of treatment should be based on the assessment of clinical activity and severity of GO. Early referral to specialized centers is fundamental for most patients with GO. Risk factors include smoking, thyroid dysfunction, high serum level of thyrotropin receptor antibodies, radioactive iodine (RAI) treatment, and hypercholesterolemia.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti, Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita, Farmacija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
